This is great new in my opinion. Looks to me that the FDA see this as a winner, I wonder if they also stumbled across other benefits that they want to discuss.
Either way I’ve been topping up on this one with every spare cent I have, I’m hoping this one might be my early retirement fund
Ann: Meeting with US FDA on Phase I Clinical Trial for RECCE 327, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
0.005(1.39%) |
Mkt cap ! $105.5M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 39.5¢ | 36.0¢ | $39.92K | 103.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34380 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 3483 | 3 |
View Market Depth
| Last trade - 10.43am 23/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |